AbbVie
ABBV
#31
Rank
ยฃ334.84 B
Marketcap
ยฃ189.52
Share price
-1.20%
Change (1 day)
41.40%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : ยฃ107.91 Billion

According to AbbVie's latest financial reports the company's total liabilities are ยฃ107.91 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

AbbVie - Total liabilities on balance sheet (from 2011 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31ยฃ101.86 B-3.01%
2024-12-31ยฃ105.02 B7.63%
2023-12-31ยฃ97.57 B-2.85%
2022-12-31ยฃ100.44 B3.43%
2021-12-31ยฃ97.11 B-3.7%
2020-12-31ยฃ100.85 B35.94%
2019-12-31ยฃ74.19 B38.91%
2018-12-31ยฃ53.41 B9.89%
2017-12-31ยฃ48.60 B-2.42%
2016-12-31ยฃ49.81 B50.32%
2015-12-31ยฃ33.13 B100.19%
2014-12-31ยฃ16.55 B10.52%
2013-12-31ยฃ14.97 B2.38%
2012-12-31ยฃ14.62 B199.62%
2011-12-31ยฃ4.88 B38.77%
2010-12-31ยฃ3.51 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
ยฃ88.40 B-18.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ64.39 B-40.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ62.84 B-41.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ8.16 B-92.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ24.77 B-77.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ50.06 B-53.61%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ50.25 B-53.43%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
ยฃ45.39 B-57.93%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
ยฃ1.13 B-98.95%๐Ÿ‡บ๐Ÿ‡ธ USA